WELCOME

FOXOF

Alveolar Rhabdomyosarcoma (ARMS), 13q14 (FOXO1 or FKHR) Rearrangement, FISH, Tissue

88271 x 2, 88291-DNA probe, each (first probe set), Interpretation and report 88271 x 2-DNA probe, each; each additional probe set (if appropriate) 88271-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271 x 2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271 x 3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

LCAF

Lung Cancer, ALK (2p23) Rearrangement, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

PLASF

Plasma Cell Proliferative Disorder, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

SRYF

Sex-Determining Region Y, Yp11.3 Deletion, FISH

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88273 w/modifier 52-Chromosomal in situ hybridization, less than 10 cells (if appropriate) 88273-Chromosomal in situ hybridization, 10-30 cells (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

SS18F

Synovial Sarcoma (SS), 18q11.2 (SS18 or SYT) Rearrangement, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

FUSF

Low-Grade Fibromyxoid Sarcoma (LGFMS), 16p11.2 (FUS or TLS) Rearrangement, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

XYMF

Known 45,X, Mosaicism Reflex Analysis, FISH, Whole Blood

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

CHRHB

Chromosome Analysis, Hematologic Disorders, Blood

88237, 88291-Tissue culture for neoplastic disorders; bone marrow, blood, Interpretation and report 88264 w/ modifier 52-Chromosome analysis with less than 20 cells (if appropriate) 88264-Chromosome analysis with 20 to 25 cells (if appropriate) 88264,88285-Chromosome analysis with greater than 25 cells (if appropriate) 88283-Additional specialized banding technique (if appropriate) 

NADF

Newborn Aneuploidy Detection, FISH

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

PADF

Prenatal Aneuploidy Detection, FISH

88271 x 2, 88291-DNA probe, each (first probe set), Interpretation and report 88271 x 2-DNA probe, each; each additional probe set (if appropriate) 88271 x 1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271 x 2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271 x 3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

TFE3F

Alveolar Soft Part Sarcoma (ASPS)/Renal Cell Carcinoma (RCC), Xp11.23 (TFE3), FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

WS7F

Williams Syndrome, 7q11.23 Deletion, FISH, Varies

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88273 w/modifier 52-Chromosomal in situ hybridization, less than 10 cells (if appropriate) 88273-Chromosomal in situ hybridization, 10-30 cells (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,